European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

Department of Health and Human Services SBIR Phase I

Department of Health and Human Services SBIR Phase I (United States): 469 grants in the last 24 months to 418 recipients; a typical grant is about €280,000. It funds most often: Feasibility studies and proof of concept. Data as of 17 November 2026; updated daily.

Grants in the last 24 months
469
Recipients
418
Total, last 24 months
≈ €150,000,000
Typical grant (median)
≈ €280,000
Open calls
0
Calls on the site
0

Open calls

No records yet.

Latest grants

Most grants went to

  1. MUCOMMUNE, LLC 4
  2. BIOTHERAPEUTICS, Inc. 4
  3. Vivid Bioinnovations, PBC 3
  4. L2 Diagnostics LLC 3
  5. XGENOMES Corp. 3
  6. Electronic Biosciences, Inc. 3
  7. Panluminate Inc 3
  8. Syntis Bio Inc 3
  9. Minnesota HealthSolutions Corporation 3
  10. Z Biotech, LLC 3

What the money buys

Who it is for

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does Department of Health and Human Services SBIR Phase I open calls?
No call is open right now.
How much is a grant from Department of Health and Human Services SBIR Phase I?
In the last 24 months the median grant was about €280,000; 469 grants, about €150,000,000 in all.
Who gets grants from Department of Health and Human Services SBIR Phase I?
Most grants in the last 24 months: MUCOMMUNE, LLC (4), BIOTHERAPEUTICS, INC. (4) and VIVID BIOINNOVATIONS, PBC (3).
What does Department of Health and Human Services SBIR Phase I fund?
Most often: Feasibility studies and proof of concept.